MAPK1 and liver cancer: To test our hypothesis, we conducted a rescue experiment and observed that knockdown of KIF15 in PSMD12-overexpressing liver cancer cells can restore the progression of tumor malignancy and the activation of the MEK-ERK signaling pathway induced by PSMD12.